Collagene idrolizzato contro placebo nel trattamento delle lesioni degenerative della cartilagine del ginocchio - Studio clinico randomizzato controllato

Title

Code

COLL-OA

Type

Sperimentale

Start Year

2022

Status

In Corso

Principal Investigator

051-6366567, 051-6366087

alessandro.dimartino@ior.it

Di Martino Alessandro, MD

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. COLL-OA

Wednesday 27 July 2022, 15:59

PG0009322_2021_COLL-OA.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Collagene idrolizzato contro placebo nel trattamento delle lesioni degenerative della cartilagine del ginocchio - Studio clinico randomizzato controllato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in